Comparing lymph node removal in robotic rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two ways of removing lymph nodes (small glands that help fight infection) during robotic surgery for mid or low rectal cancer. It aims to see whether removing fewer lymph nodes may be just as effective and cause fewer side effects than removing a larger group of them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with rectal adenocarcinoma (a type of rectal cancer) through a biopsy.
- Your tumor is located 10 cm or less from the anal verge (the opening of the anus).
- Imaging tests have confirmed the cancer has not spread to certain lymph nodes or other organs (no distant metastasis).
- You are eligible for robotic surgery and have not had other major cancers in the past (except certain early-stage skin or cervical cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how much the lymph nodes respond to chemoradiation before surgery in people with locally advanced rectal cancer. It aims to understand if that response can predict long-term results and guide future treatment choices.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This trial compares two types of robotic surgery for rectal cancer to see if they are equally safe and effective. It helps patients understand which approach might be better for their recovery and outcomes.
This trial focuses on rectal cancer that has come back in the side lymph nodes near the pelvis. It tests how to treat that “lateral nodal recurrence” to improve outcomes by targeting these specific lymph nodes.
This study compares two ways of performing rectal cancer surgery: robotic surgery and a newer technique called TaTME (transanal total mesorectal excision). It aims to see which approach has better outcomes for patients. If you're having surgery for rectal cancer, this trial might help you get access to advanced surgical options.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.